Back

Factor XI inhibition uncoupled: mechanistic insights and rationale

30 August 2024 (15:30 - 15:40)
Organised by: Logo
Congress Presentation Part of: Advances in thrombosis management: evaluating current and emerging anticoagulation strategies Thrombosis, Platelets, and Coagulation Open Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Jeffrey Weitz

Thrombosis & Atherosclerosis Research Institute (TaARI), Hamilton (Canada)

4 More presentations in this session

Presentation thumbnail
Welcome and Introductions
Professor V. Kunadian (Newcastle-Upon-Tyne, GB)
Slides Video
Presentation thumbnail
Contemporary thrombosis management -- state of the state
Professor V. Kunadian (Newcastle-Upon-Tyne, GB)
Slides Video
Presentation thumbnail
Factor XI inhibition: clinical view on current research and future implications
Professor C. Lam (Singapore, SG)
Slides Video
Presentation thumbnail
Program summary and conclusion
Professor V. Kunadian (Newcastle-Upon-Tyne, GB)
Slides Video

Access the full session

Session thumbnail
Advances in thrombosis management: evaluating current and emerging anticoagulation strategies
Video

The Event

Event poster

ESC Congress 2024

30 August 2024 15:30 CET
You may be interested in
thumbnail
Congress Presentation
Targeting factor XI: innovations in anticoagulation
thumbnail
Congress Presentation
Uncoupling ischaemic and bleeding complications: are new factor XI inhibitors too good to be true?
thumbnail
Congress Presentation
Program summary and conclusion

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources